Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Hepatitis A
English (EN)
SAGE documentation
2022
Clear all
Type of publications
NITAG documentation
(51)
SAGE documentation
(20)
Scientific publications
(1)
Topics
Background paper
(1)
Evidence to recommendation table
(1)
GRADE table
(3)
Position paper
(11)
SAGE background document
(4)
Regions
Countries
Diseases
COVID-19
(16)
Hepatitis A
(4)
Human papillomavirus (HPV)
(2)
Influenza
(2)
Malaria
(6)
Mpox
(4)
Vaccine topics
Target population
Methodological quality (AMSTAR 2)
Publication date
2022
(20)
2023
(2)
2021
(4)
2020
(2)
2018
(7)
2014
(1)
2012
(6)
Available to download in languages
English (EN)
(20)
20 results found
2022
∙
SAGE
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
2022
∙
SAGE
Good practice statement on the use of second booster doses for COVID-19 vaccines
2022
∙
SAGE
Interim recommendations for use of the Bharat Biotech BBV152 COVAXIN® vaccine against COVID-19
2022
∙
SAGE
Background document on the Cansino Ad5-nCoV-S vaccine (Convidecia ®) against COVID-19
2022
∙
SAGE
Annexes to the interim recommendations for use of the Cansino Ad5-nCoV-S vaccine (Convidecia ®) against COVID-19
2022
∙
SAGE
Background document on the Valneva VLA2001 vaccine against COVID-19
2022
∙
SAGE
Annexes to the interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19
2022
∙
SAGE
Interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19
2022
∙
SAGE
Interim recommendations for use of the Cansino Ad5-nCoV-S vaccine (Convidecia ®) against COVID-19
2022
∙
SAGE
Interim statement on the use of additional booster doses of Emergency Use Listed mRNA vaccines against COVID-19
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register